Balázs Jóri

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 5

Top Topics

Tyrosine Kinase

Circulating Tumor

Top Venues

Current oncology (Toronto, Ont.)

Translational lung cancer research

This page only lists publications with an associated author ORCID identifier.

Publications

Balázs Jóri, Otto Bundschuh, Markus Falk, Lukas C Heukamp, Alexander Kluge, Markus Tiemann, Kay C Willborn, Johannes Woitzik, Frank Griesinger
Intracranial response to capmatinib after progression on crizotinib in a patient with MET exon 14 skipping non-small cell lung cancer-a case report. Translational lung cancer research 13 (7) (2024)
Balázs Jóri, Otto Bundschuh, Markus Falk, Lukas C Heukamp, Alexander Kluge, Markus Tiemann, Kay C Willborn, Johannes Woitzik, Frank Griesinger
Intracranial response to capmatinib after progression on crizotinib in a patient with MET exon 14 skipping non-small cell lung cancer-a case report. Translational lung cancer research 13 (7) (2024)
Eva Maria Willing, Claudia Vollbrecht, Christine Vössing, Peggy Weist, Simon Schallenberg, Johanna M Herbst, Stefanie Schatz, Balázs Jóri, Guillaume Bataillon, Philipp Harter, Vanda Salutari, Antonio Gonzáles Martin, Ignace Vergote, Nicoletta Colombo, Julia Roeper, Tobias Berg, Regina Berger, Bettina Kah, Trine Jakobi Noettrup, Markus Falk, Kathrin Arndt, Andreas Polten, Isabelle L Ray-Coquard, Franziska Selzam, Judith Pirngruber, Stefanie Schmidt, Michael Hummel, Markus Tiemann, David Horst, Jalid Sehouli, Eric Pujade-Lauraine, Katharina Tiemann, Elena Ioana Braicu, Lukas C Heukamp
Development of the NOGGO GIS v1 Assay, a Comprehensive Hybrid-Capture-Based NGS Assay for Therapeutic Stratification of Homologous Repair Deficiency Driven Tumors and Clinical Validation. Cancers 15 (13) (2023)
Balázs Jóri, Christine Vössing, Judith Pirngruber, Eva Maria Willing, Kathrin Arndt, Markus Falk, Markus Tiemann, Lukas C Heukamp, Petra Hoffknecht
The Combined Therapy of Cabozantinib, Crizotinib, and Osimertinib in a Lung Cancer Patient with Acquired MET Amplification and Resistance Mutations. Current oncology (Toronto, Ont.) 30 (10) (2023)
Balázs Jóri, Markus Falk, Iris Hövel, Peggy Weist, Markus Tiemann, Lukas C Heukamp, Frank Griesinger
Acquired G2032R Resistance Mutation in ROS1 to Lorlatinib Therapy Detected with Liquid Biopsy. Current oncology (Toronto, Ont.) 29 (9) (2022)